Skip to content
Screener

Reported November 12, 2026 · Before market open

Revenue$3.6B
EPS$0.07

Next report

Feb 11, 2027 (in 3 months)

FAQ

When did Bentley Pharmaceuticals report Q3 2026 earnings?
Bentley Pharmaceuticals (BNT) reported Q3 2026 earnings on November 12, 2026 before market open.
What were Bentley Pharmaceuticals's Q3 2026 revenue and EPS?
Bentley Pharmaceuticals reported revenue of $3.6B and eps of $0.07 for Q3 2026.
How did Bentley Pharmaceuticals's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.3% from $3.1B a year earlier and eps grew 16.7% from $0.06.